Rab18 is reduced in pituitary tumors causing acromegaly and its overexpression reverts growth hormone hypersecretion.

PubWeight™: 0.84‹?›

🔗 View Article (PMID 18349058)

Published in J Clin Endocrinol Metab on March 18, 2008

Authors

Rafael Vazquez-Martinez1, Antonio J Martinez-Fuentes, Marina R Pulido, Luis Jimenez-Reina, Ana Quintero, Alfonso Leal-Cerro, Alfonso Soto, Susan M Webb, Nuria Sucunza, Frederic Bartumeus, Pedro Benito-Lopez, Maria A Galvez-Moreno, Justo P Castaño, Maria M Malagon

Author Affiliations

1: Department of Cell Biology, Physiology, and Immunology, Campus de Rabanales. Edificio Severo Ochoa, University of Cordoba, Cordoba, Spain.

Articles by these authors

Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA). Eur J Endocrinol (2004) 2.25

Hypothyroidism as a cause of rhabdomyolysis. Endocr J (2002) 1.70

Hippocampal dysfunction in cured Cushing's syndrome patients, detected by (1) H-MR-spectroscopy. Clin Endocrinol (Oxf) (2013) 1.43

Long-term safety of pegvisomant in patients with acromegaly: comprehensive review of 1288 subjects in ACROSTUDY. J Clin Endocrinol Metab (2012) 1.24

Intermittent motion in desert locusts: behavioural complexity in simple environments. PLoS Comput Biol (2012) 1.23

Animal movement, search strategies and behavioural ecology: a cross-disciplinary way forward. J Anim Ecol (2010) 1.18

Prognostic factors in survival of patients with stage Ta and T1 bladder urothelial tumors: the role of G1-S modulators (p53, p21Waf1, p27Kip1, cyclin D1, and cyclin D3), proliferation index, and clinicopathologic parameters. Am J Clin Pathol (2004) 1.16

Metabolic regulation of ghrelin O-acyl transferase (GOAT) expression in the mouse hypothalamus, pituitary, and stomach. Mol Cell Endocrinol (2009) 1.14

Resveratrol improves adipose insulin signaling and reduces the inflammatory response in adipose tissue of rhesus monkeys on high-fat, high-sugar diet. Cell Metab (2013) 1.14

Emerging therapies for multidrug resistant Acinetobacter baumannii. Trends Microbiol (2013) 1.13

The European Registry on Cushing's syndrome: 2-year experience. Baseline demographic and clinical characteristics. Eur J Endocrinol (2011) 1.13

The effects of spatially heterogeneous prey distributions on detection patterns in foraging seabirds. PLoS One (2012) 1.11

Regulation of pituitary cell function by adiponectin. Endocrinology (2006) 1.11

Squamous differentiation in primary urothelial carcinoma of the urinary tract as seen by MAC387 immunohistochemistry. J Clin Pathol (2006) 1.10

How superdiffusion gets arrested: ecological encounters explain shift from Lévy to Brownian movement. Proc Biol Sci (2013) 1.07

Persistent body fat mass and inflammatory marker increases after long-term cure of Cushing's syndrome. J Clin Endocrinol Metab (2009) 1.06

Quality of life (QOL) in patients with acromegaly is severely impaired: use of a novel measure of QOL: acromegaly quality of life questionnaire. J Clin Endocrinol Metab (2005) 1.05

Chromogranin A promotes peptide hormone sorting to mobile granules in constitutively and regulated secreting cells: role of conserved N- and C-terminal peptides. J Biol Chem (2009) 1.05

New approaches to human mobility: using mobile phones for demographic research. Demography (2013) 1.03

Identification and characterization of two novel truncated but functional isoforms of the somatostatin receptor subtype 5 differentially present in pituitary tumors. J Clin Endocrinol Metab (2009) 1.03

Regulation of cyclic adenosine 3',5'- monophosphate signaling and pulsatile neurosecretion by Gi-coupled plasma membrane estrogen receptors in immortalized gonadotrophin-releasing hormone neurons. Mol Endocrinol (2003) 1.02

A novel human ghrelin variant (In1-ghrelin) and ghrelin-O-acyltransferase are overexpressed in breast cancer: potential pathophysiological relevance. PLoS One (2011) 1.01

Acromegaly Quality of Life Questionnaire (AcroQoL). Health Qual Life Outcomes (2004) 1.00

Unified effects of aggregation reveal larger prey groups take longer to find. Proc Biol Sci (2011) 1.00

Intracellular signaling mechanisms mediating ghrelin-stimulated growth hormone release in somatotropes. Endocrinology (2003) 0.99

Understanding the multifactorial control of growth hormone release by somatotropes: lessons from comparative endocrinology. Ann N Y Acad Sci (2009) 0.98

The stromal-vascular fraction of adipose tissue contributes to major differences between subcutaneous and visceral fat depots. Proteomics (2010) 0.98

Mapping CushingQoL scores onto SF-6D utility values in patients with Cushing's syndrome. Patient (2013) 0.97

Ant search strategies after interrupted tandem runs. J Exp Biol (2010) 0.96

The L-α-lysophosphatidylinositol/GPR55 system and its potential role in human obesity. Diabetes (2011) 0.96

Regulation of cyclic adenosine 3',5'-monophosphate signaling and pulsatile neurosecretion by Gi-coupled plasma membrane estrogen receptors in immortalized gonadotropin-releasing hormone neurons. Mol Endocrinol (2003) 0.95

Kisspeptin regulates gonadotroph and somatotroph function in nonhuman primate pituitary via common and distinct signaling mechanisms. Endocrinology (2011) 0.95

Dimerization of G protein-coupled receptors: new avenues for somatostatin receptor signalling, control and functioning. Mol Cell Endocrinol (2007) 0.95

Cortistatin is not a somatostatin analogue but stimulates prolactin release and inhibits GH and ACTH in a gender-dependent fashion: potential role of ghrelin. Endocrinology (2011) 0.95

In vivo and in vitro structure-activity relationships and structural conformation of Kisspeptin-10-related peptides. Mol Pharmacol (2009) 0.93

Verbal and visual memory performance and hippocampal volumes, measured by 3-Tesla magnetic resonance imaging, in patients with Cushing's syndrome. J Clin Endocrinol Metab (2011) 0.93

Human growth hormone replacement in adult hypopituitary patients: long-term effects on body composition and lipid status--3-year results from the HypoCCS Database. J Clin Endocrinol Metab (2002) 0.93

Assessment of quality of life in patients with uncontrolled vs. controlled acromegaly using the Acromegaly Quality of Life Questionnaire (AcroQoL). Clin Endocrinol (Oxf) (2005) 0.92

Proteomic profiling of adipose tissue from Zmpste24-/- mice, a model of lipodystrophy and premature aging, reveals major changes in mitochondrial function and vimentin processing. Mol Cell Proteomics (2011) 0.92

Period of gestational diabetes mellitus diagnosis and maternal and fetal morbidity. Acta Obstet Gynecol Scand (2005) 0.92

A potential inhibitory role for the new truncated variant of somatostatin receptor 5, sst5TMD4, in pituitary adenomas poorly responsive to somatostatin analogs. J Clin Endocrinol Metab (2010) 0.92

Identification and characterization of new functional truncated variants of somatostatin receptor subtype 5 in rodents. Cell Mol Life Sci (2010) 0.92

Obestatin regulates adipocyte function and protects against diet-induced insulin resistance and inflammation. FASEB J (2012) 0.91

Rab18 inhibits secretory activity in neuroendocrine cells by interacting with secretory granules. Traffic (2007) 0.90

Heterogeneous genetic background of the association of pheochromocytoma/paraganglioma and pituitary adenoma: results from a large patient cohort. J Clin Endocrinol Metab (2014) 0.90

Intragastric balloon-induced satiety is not mediated by modification in fasting or postprandial plasma ghrelin levels in morbid obesity. Obes Surg (2007) 0.90

Molecular pathogenesis of neuroendocrine tumors: implications for current and future therapeutic approaches. Clin Cancer Res (2013) 0.90

Activity of host antimicrobials against multidrug-resistant Acinetobacter baumannii acquiring colistin resistance through loss of lipopolysaccharide. Antimicrob Agents Chemother (2014) 0.89

Adiponectin receptors form homomers and heteromers exhibiting distinct ligand binding and intracellular signaling properties. J Biol Chem (2012) 0.89

Expression of the ghrelin and neurotensin systems is altered in the temporal lobe of Alzheimer's disease patients. J Alzheimers Dis (2010) 0.89

Prognostic significance of human pituitary tumor-transforming gene immunohistochemical expression in differentiated thyroid cancer. J Clin Endocrinol Metab (2006) 0.89

Postprandial inflammatory response in adipose tissue of patients with metabolic syndrome after the intake of different dietary models. Mol Nutr Food Res (2011) 0.88

A reappraisal of the medical therapy with steroidogenesis inhibitors in Cushing's syndrome. Clin Endocrinol (Oxf) (2012) 0.88

Somatostatin and its receptors contribute in a tissue-specific manner to the sex-dependent metabolic (fed/fasting) control of growth hormone axis in mice. Am J Physiol Endocrinol Metab (2010) 0.88

Linking animal movement to site fidelity. J Math Biol (2011) 0.87

Somatostatin and its receptors from fish to mammals. Ann N Y Acad Sci (2010) 0.87

Mechanistic analysis of the search behaviour of Caenorhabditis elegans. J R Soc Interface (2014) 0.87

Evidence of cognitive and neurophysiological impairment in patients with untreated naive acromegaly. J Clin Endocrinol Metab (2010) 0.86

Expression of proinflammatory, proatherogenic genes is reduced by the Mediterranean diet in elderly people. Br J Nutr (2011) 0.86

Mediterranean diet supplemented with coenzyme Q10 induces postprandial changes in p53 in response to oxidative DNA damage in elderly subjects. Age (Dordr) (2011) 0.86

Role of ghrelin system in neuroprotection and cognitive functions: implications in Alzheimer's disease. Peptides (2011) 0.86

Long-term improvement of quality of life during growth hormone (GH) replacement therapy in adults with GH deficiency, as measured by questions on life satisfaction-hypopituitarism (QLS-H). J Clin Endocrinol Metab (2004) 0.86

First steps towards a vaccine against Acinetobacter baumannii. Curr Pharm Biotechnol (2013) 0.86

Clinical consequences of Cushing's syndrome. Pituitary (2012) 0.86

GDNF is required for neural colonization of the pancreas. Development (2013) 0.85

Are somatostatin and cortistatin two siblings in regulating endocrine secretions? In vitro work ahead. Mol Cell Endocrinol (2007) 0.85

Changes in acromegaly treatment over four decades in Spain: analysis of the Spanish Acromegaly Registry (REA). Pituitary (2013) 0.84

Treatment of acromegaly improves quality of life, measured by AcroQol. Clin Endocrinol (Oxf) (2007) 0.84

A clinical profile of memory impairment in humans due to endogenous glucocorticoid excess. Clin Endocrinol (Oxf) (2008) 0.84

Expression of Somatostatin, cortistatin, and their receptors, as well as dopamine receptors, but not of neprilysin, are reduced in the temporal lobe of Alzheimer's disease patients. J Alzheimers Dis (2010) 0.84

Ghrelin gene products, receptors, and GOAT enzyme: biological and pathophysiological insight. J Endocrinol (2013) 0.84

A link between bone mineral density and serum adiponectin and visfatin levels in acromegaly. J Clin Endocrinol Metab (2009) 0.83

Homologous and heterologous regulation of pituitary receptors for ghrelin and growth hormone-releasing hormone. Endocrinology (2004) 0.83

Insulin and IGF-I inhibit GH synthesis and release in vitro and in vivo by separate mechanisms. Endocrinology (2013) 0.83

Ghrelin is produced by and directly activates corticotrope cells from adrenocorticotropin-secreting adenomas. J Clin Endocrinol Metab (2006) 0.83

Mitochondria in metabolic disease: getting clues from proteomic studies. Proteomics (2014) 0.83

Cortistatin inhibits migration and proliferation of human vascular smooth muscle cells and decreases neointimal formation on carotid artery ligation. Circ Res (2013) 0.83

Discrimination between alternate membrane protein topologies in living cells using GFP/YFP tagging and pH exchange. Cell Mol Life Sci (2010) 0.83

Truncated somatostatin receptors as new players in somatostatin-cortistatin pathophysiology. Ann N Y Acad Sci (2011) 0.83

Psychometric performance of the CushingQoL questionnaire in conditions of real clinical practice. Eur J Endocrinol (2012) 0.83

Deleterious effects of glucocorticoid replacement on bone in women after long-term remission of Cushing's syndrome. J Bone Miner Res (2009) 0.82

Peripubertal-onset but not adult-onset obesity increases IGF-I and drives development of lean mass, which may lessen the metabolic impairment in adult obesity. Am J Physiol Endocrinol Metab (2012) 0.82

Expression of functional KISS1 and KISS1R system is altered in human pituitary adenomas: evidence for apoptotic action of kisspeptin-10. Eur J Endocrinol (2010) 0.82

Role of nitric oxide in D-galactosamine-induced cell death and its protection by PGE1 in cultured hepatocytes. Nitric Oxide (2003) 0.81

Homologous and heterologous in vitro regulation of pituitary receptors for somatostatin, growth hormone (GH)-releasing hormone, and ghrelin in a nonhuman primate (Papio anubis). Endocrinology (2011) 0.81